The Chemours Company filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 9, 2026, announcing the posting of its September 2026 Investor Presentation. The filing indicates that the presentation has been uploaded to the Investor Relations section of the company's website and will be utilized during upcoming meetings with investors, analysts, and other interested parties.
The presentation, furnished as Exhibit 99.1, contains forward-looking statements regarding the company's future performance. These statements are subject to various risks and uncertainties, including the resolution of environmental liabilities, regulatory inquiries, changes in environmental regulations, and general economic conditions. The document also details the company's use of non-GAAP financial measures, such as Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, and Free Cash Flow, which management believes provide greater transparency regarding operational decision-making.
Financial data presented in the filing, based on trailing twelve-month figures as of June 30, 2026, highlights the company's three primary business segments: Titanium Technologies, Advanced Performance Materials, and Thermal & Specialized Solutions. For the combined company, the presentation reports Net Sales of $5.8 billion and Adjusted EBITDA of $733 million, with an Adjusted EBITDA Margin of 13%. The company notes a Free Cash Flow Conversion of 7% and a Net Leverage Ratio of 4.7x.
Within the segments, Titanium Technologies reports Net Sales of $2.2 billion and Adjusted EBITDA of $343 million. Advanced Performance Materials reports Net Sales of $2.4 billion and Adjusted EBITDA of $114 million. Thermal & Specialized Solutions reports Net Sales of $1.2 billion and Adjusted EBITDA of $57 million. The company outlines strategic progress, including a focus on the 'Pathway to Thrive' execution through 2027 and driving growth in high-value end markets such as data centers, semiconductors, and AI infrastructure.